Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sennosides are stimulant laxatives derived from the leaves and fruit of the plant *Senna alexandrina*. They are used primarily to treat occasional constipation and to empty the large intestine before surgery or certain medical procedures. Sennosides work by irritating the lining of the bowel, which increases intestinal motility and fluid secretion, resulting in a laxative effect. The active components, mainly sennoside A and B, are metabolized by gut bacteria into rheinanthrone, which stimulates peristalsis in the colon and reduces water reabsorption by decreasing aquaporin 3 expression. This leads to increased fecal water content and promotes bowel movements. Sennosides are available over-the-counter in various oral forms (tablets, liquids) as well as rectal preparations[1][2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sennosides.